3. Outline:
1.RNA editing
2.RNA editing mechanisms
2.1 Editing by deamination
2.2 ADARs
2.3 Examples of A-to-I editing
2.4 Effects of RNA editing by ADARs enzyme
2.5 APOBECs
2.6 Examples of C-to-U editing
2.7 Effects of RNA editing by APOBECs enzyme
2.8 Insertion/Deletion Editing
3.Significance of RNA editing
4.Nervous system and RNA editing
5.Immune system and RNA editing
6.RNA editing and cancers
6.1 RNA editing and cancers: examples
7.Therapeutic intervention
8.Reference
3
4. 1. RNA editing
Definition: Any process, other than splicing, that
results in a change in the sequence of an RNA transcript
Relatively rare
Discovered in trypanosome mitochondria
Also occurs in a few chloroplast genes of plants, and at
least a few nuclear genes in mammals.
4
7. 2.2 ADARs
Adenosine Deaminases Acting on RNA
Binds to double stranded RNA
Convert adenosine to inosine (A-to-I),which the ribosome
translates as a G. Thus a CAG codon (for Gln) can be
converted to a CGG codon (for Arg).
7
10. 2.5. APOBECs
Apolipoprotein B mRNA editing Complexes
Converts cytosine to uracil (C-to-U)
in RNA
single-stranded DNA
10
11. 2.6. Examples of C-to-U editing
Apolipoprotein B gene (in humans).
Apo B100 is expressed in the liver
Apo B48 is expressed in the intestines.
11
13. 2.8.Insertion/Deletion Editing
Requires a special class of RNA called guide RNA (gRNA)
Multiple U’s are inserted into specific region of mRNAs
after transcription (or U’s may be deleted).
Found in the mitochondria of trypanosomes
Has also been found occur with
RNA transcripts in the mitochondria of the slime mold
Physarum polycephalum.
In measles virus transcripts
13
15. 3. Significance of RNA editing
It is essential in regulating gene expression of organisms.
RNA editing mutant was reported with strong defects in
organelle development.
Deficiency diseases(mostly cancers)
It is a mechanism to increase the number of different proteins
available without the need to increase the number of genes in
the genome.
May help protect the genome against some viruses
15
16. 4. Nervous system and RNA editing
ADARs-mediated RNA editing
In both coding and noncoding transcriptomes
Editing in non-coding regions (such as
microRNA and 3´ UTR) is more frequent than in
coding regions
It is important for avoiding neurological diseases
16
17. 5. Immune system and RNA editing
The replication of hepatitis delta virus (HDV).
ADAR1-S and ADAR1-L are involved in HDV editing
ADAR1-S functions in unstimulated cells
ADAR1-L functions in IFN-alpha-stimulated cells
APOBEC3 proteins play a vital role in innate defense
against mobile genetic elements such as viruses
For example, APOBEC3G has antiviral properties
(inactivate the HIV)
17
18. 6. RNA editing and cancers
A-to-I editing is involved in human embryogenesis
This was found by studying the differentiation status of
pluripotent human embryonic stem cells
RNA regulation can modulate the expression of
oncogenes or tumor suppressor genes
So A-to-I editing may contribute to cancer development
and progression
18
19. 6.1.RNA editing and cancers: examples
ADAR1 down regulation leads to regression of established
Chronic Myelogenous Leukemia in mice.
Down regulation of ADAR2 inhibited cellular proliferation
of pediatric astrocytoma and glioblastoma.
ADAR3 mRNA was decreased in glioblastoma multiform
(a brain tumor).
19
21. 6.1.RNA editing and cancers: more examples
ADARs
APOBECs
21
Brain
Bladder
Leukemia
Liver
Breast
General
Reduced editing of GluR in
malignant gliomas
Reduced editing levels in tumors
Disease-associated alternative
splicing of PTPN6 caused by RNA
hyper-editing
APOBEC1-mediated editing of NAT1
mRNA in liver tumors
APOBEC3B upregulated in breast
cancer cell lines
APOBEC signatures are observed in
multiple cancer types
22. 7. Therapeutic intervention
RNA editing has been suggested to be a therapeutic
target for CNS disorders
For example, RNA editing of the 5HT2C receptor may
affect cell signaling, drug response, and brain function.
A-to-I editing can also modulate the drug response of
some channels, such as Kv1.1 channel
Drugs for inhibiting RNA editing enzymes
22
23. 7. Therapeutic intervention(…)
Editing enzyme levels could be used as prognostic markers
for early detection of cancer and to determine post-
therapeutic outcomes.
Elevated APOBEC3B levels would potentially represent a
promising biomarker for certain cancers like breast cancer
low levels of ADAR1 have been associated with high risk of
childhood lymphoma
23
24. 8.Reference
The emerging role of RNA and DNA editing in cancer
Review Article
Biochimica et Biophysica Acta (BBA) – Review
on Cancer, Volume 1845, Issue 2, April 2014, Pages 308-316
Lotta Avesson, Guy Barry
RNA editing and drug discovery for cancer therapy.
Huang WH, Tseng CN, Tang JY, Yang CH, Liang SS, Chang HW.
Scientific World Journal. 2013 Apr 24;2013:804505. doi:
10.1155/2013/804505. Print 2013. Review.
24